INTRODUCTION
============

Prostate calcifications are a common finding during transrectal prostate ultrasound in both healthy subjects and patients undergoing prostate biopsy \[[@B1],[@B2]\], but their clinical role and etiopathogenesis is not fully understood. Some authors state that prostate stones and calcifications are the result of inspissated prostatic secretions, with a core surrounded by concentric layers of calcium apatite \[[@B3]\]. Prostate calcifications may also be the result of an inflammatory process because of aging or intraprostatic reflux. Calcifications have been reported to progress and cause mechanical obstruction, smooth muscle contraction, and voiding symptoms \[[@B4],[@B5]\]. However, we are still far from understanding the clinical significance and etiopathogenesis of prostate calcifications. It is generally accepted that the incidence of prostatic calcification increases with age \[[@B6]\] and that the incidence is somehow related to chronic prostatitis or chronic pelvic pain syndrome in young men \[[@B5],[@B7]\]. Moreover, prostate calcifications seem to play an important role in lower urinary tract symptoms (LUTS), but the relationship between prostate calcifications and LUTS remains elusive \[[@B1]\].

Recently, interest in the role of biofilm-producing bacteria in the development of acute and chronic prostatitis has increased \[[@B8],[@B9]\]. Bartoletti and coworkers demonstrated the role of biofilm-producing bacteria for the persistence of symptoms in patients with chronic bacterial prostatitis, irrespective of the administration of antibiotic treatment \[[@B9]\]. From these observations, we hypothesized that biofilm-producing bacteria may play a role in the genesis of prostate calcifications. In the present study, we tested a new methodology for identifying microbial biofilms at the calcification surface by using microbial culture and ultrastructural characterization techniques in a small cohort of patients.

MATERIALS AND METHODS
=====================

1. Study population
-------------------

Ten consecutive patients who underwent radical prostatectomy for prostate cancer were enrolled in this study between January and June 2015. Subjects were selected from patients who had prostate calcifications as demonstrated on transrectal ultrasound-guided prostate biopsy. The day before surgery, all patients underwent a clinical evaluation, underwent Meares-Stamey testing, and filled in the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) and the International Prostate Symptom Score (IPSS) questionnaire. Immediately after removal, the prostates were examined by ultrasonography under sterile conditions in the operating room. One or two core biopsy specimens were taken from the site of prostate calcification and subjected to microbiological and ultrastructural analyses.

2. Questionnaires
-----------------

The patients\' clinical symptoms were assessed by using the validated Italian versions of the NIH-CPSI \[[@B10]\] and the IPSS \[[@B11]\]. The questionnaires were self-administered upon the patients\' arrival at Department of Urology, Santa Chiara Regional Hospital, Trento, Italy.

3. Sample collection from Meares-Stamey testing and microbiological procedures
------------------------------------------------------------------------------

All samples from the Meares-Stamey test were collected and immediately brought to the laboratory under refrigeration. Aliquots were analyzed for cultures and processed for DNA extraction and polymerase chain reaction as described by Mazzoli et al. \[[@B12]\] and Cai et al. \[[@B13]\]. All specimens were examined for microbiological cultures of common bacteria and yeasts, and DNA extraction and mucosal immunoglobulin A evaluation was performed for diagnosis of *Chlamydia trachomatis* infection. All patients underwent the Meares-Stamey test as described by Mazzoli et al. \[[@B12]\]. Microorganisms were identified and tested for antibiotic susceptibility by using the Vitek II semiautomated system for microbiology (BioMerieux, Florence, Italy) \[[@B12],[@B13]\].

4. Ultrastructural and microbiological analyses of prostate biopsy specimens
----------------------------------------------------------------------------

From the first five patients, two prostate core biopsy specimens were obtained for both ultrastructural and microbiological analyses, respectively. From the subsequent five patients, only one prostate core biopsy specimen was available for ultrastructural analysis from each patient. Each biopsy specimen was obtained under sterile conditions from the removed prostate, immediately after surgery, and collected in a screw-capped sterile container with 5 mL of sterile saline. All collected biopsy specimens were sent to the laboratory for ultrastructural and microbiological analyses within 2 hours of sampling.

5. Ultrastructural analysis of prostate biopsy specimens
--------------------------------------------------------

Each biopsy specimen was fixed in phosphate-buffered 4% formalin for ultrastructural analysis by scanning electron microscopy (SEM). After 24 hours of fixation, the specimen was washed twice in distilled water, dehydrated in ascending hydro-alcoholic solutions, vacuum dried, and mounted on an aluminum stub with carbon-conductive and gold-sputtered tape. The sample was imaged in an XL30 FEG-FEI scanning electron microscope in high-vacuum mode at a magnification ranging from 50× to 10,000×. Any micromorphology compatible with microbial biofilm or tissue calcification was inspected and documented by collecting a set of digital micrographs, in line with Cai et al. \[[@B14]\]. The crystal composition of calcifications was assessed by using the energy-dispersive X-ray spectroscope integrated in the SEM, in line with Cai et al. \[[@B15]\].

6. Microbiological analysis of prostate biopsy specimens
--------------------------------------------------------

Prostate biopsy specimens were homogenized in 5 mL of sterile saline by using a tissue grinder (Ultra Turrax; IKA-Werke, Staufen, Germany) to dislodge the bacterial biofilm from tissues and calcifications. Homogenate fluid was then concentrated by centrifugation at 3,500 rpm for 10 minutes, and 10 µL of the sediment was plated on 5% sheep blood agar, chocolate agar, Shaedler K-van agar, and Shaedler agar. Residual homogenate concentrate was inoculated in tryptic soy broth for enrichment. Inoculated plates were incubated at 37℃ in carbon dioxide (5% sheep blood and chocolate agar) or in anaerobiosis (Shaedler K-van and Shaedler agar). Inoculated solid media were incubated at 37℃ for 5 days. Colony-forming units on solid media were enumerated at 24 and 48 hours and after 5 days of incubation. Liquid media were checked daily for turbidity. In case of growth, subcultures for strain isolation were performed on the same solid media reported above. Isolates were identified by matrix assisted laser desorption ionization time-of-flight.

7. Ethical considerations
-------------------------

No procedures or biological sampling used in this study influenced the normal clinical practice or outcome for prostate cancer patients. For this reason, when the ethical committee was asked about this study, they responded that authorization was not needed.

RESULTS
=======

1. Patient characteristics and Meares-Stamey test results
---------------------------------------------------------

Ten consecutive patients were considered in this series (median age, 64 years; range, 57 to 72 years). The clinical characteristics of the patients are presented in [Table 1](#T1){ref-type="table"}. No patient reported LUTS. Only one patient had a positive result on a Meares-Stamey test for *Escherichia coli*. The remaining patients were negative for common bacteria and yeast and displayed no leukocyturia in any sample obtained from Meares-Stamey testing.

2. Microbiological results from prostate core biopsies
------------------------------------------------------

Two patients out of five (40%) showed bacterial growth on the microbiological analysis of the prostate core biopsy specimens. The following strains were isolated: *Enterococcus faecalis*, *Enterococcus raffinosus*, and *Citrobacter freundii*. One single biopsy showed growth of two microbial strains: *E. faecalis* and *E. raffinosus*. *C. freundii* was isolated from a different patient biopsy sample.

3. Ultrastructural analysis of prostate core tissue
---------------------------------------------------

The SEM analysis revealed the presence of tissue calcifications in 6 of 10 (60%) of the analyzed biopsy specimens. Calcifications varied in size from a few to several hundred micrometers ([Fig. 1A, B](#F1){ref-type="fig"}). High-magnification imaging of the calcification surface showed a crystalline structure ([Fig. 1C](#F1){ref-type="fig"}) with protein residuals and a possible extracellular polymeric matrix from the microbial biofilm. The crystal composition varied among the patients, showing the presence of calcium and phosphorus or calcium, phosphorus, and magnesium. Round structures with a smooth surface and an average diameter ranging from 10 to 50 µm and morphologically compatible with corpora amylacea were also found in some biopsy specimens ([Fig. 2A, B](#F2){ref-type="fig"}). Several intratissual aggregates of microorganisms with coccoid morphology with an extracellular polymeric matrix were clearly identified in 1 of 10 (10%) of the analyzed biopsy specimens ([Fig. 2C](#F2){ref-type="fig"}). Two additional samples showed areas with micromorphology compatible with a microbial biofilm, but artifacts due to sample collection and preparation did not allow for a precise association with microorganisms.

4. Correlation between ultrastructural analysis and microbiological results
---------------------------------------------------------------------------

In our series of patients examined by SEM, we clearly identified the presence of intratissual microbial biofilms in prostate core tissue. The same patients had positive cultures for *E. faecalis* and *E. raffinosus* from prostate core biopsy specimens, thus confirming the SEM findings of coccoid microbial biofilms.

DISCUSSION
==========

1. Main findings
----------------

Although prostatic calculi have long been recognized \[[@B16],[@B17]\], and the relationship of urinary infections to the development of prostatic calculi and carcinoma has already been proposed \[[@B18],[@B19]\], this study is the first to perform ultrastructural and microbiological analyses of prostate calcifications. Our findings suggest a significant role of bacterial biofilms in the genesis and development of these calcifications. A previous study from Dessombz and coworkers that used SEM and infrared spectroscopy on 23 prostatic stones revealed a high occurrence of bacterial imprints, revealing a past or present infection of the prostate tissue \[[@B20]\]. Inflammation induced by an infection may lead to cancerization of the tissue. However, no direct observation of microorganisms organized in microcolonies embedded in the extracellular matrix has been reported. To our knowledge, no relationship between a specific bacterial strain and prostate calcification has been reported in the literature so far. The results of this study may have several clinical implications, which are addressed below.

2. Results in the context of previous work
------------------------------------------

The role of bacterial biofilms is well known in urological infections, in particular, in chronic bacterial prostatitis \[[@B9],[@B21]\]. Several authors have demonstrated the relationship between bacterial biofilms and antibiotic-resistant *E. coli* strains causing relapse of symptoms \[[@B16]\]. Antibiotic treatment is often unable to eradicate a microbial biofilm structure formed by strong biofilm-producer microorganisms, although the same antibiotic treatment is effective on planktonic bacteria \[[@B9],[@B22],[@B23]\]. In a cohort of chronic prostatitis patients treated with fluoroquinolones, Bartoletti and coworkers reported that 58.6% had negative microbiological tests after 3 months of antibiotic treatment \[[@B9]\]. However, only 16% of those patients reported a long-term improvement of symptoms \[[@B8]\]. This is in accordance with the fact that microbial biofilms harbor bacteria that can tolerate antibiotic treatment, the so-called "biofilm persister cells" \[[@B22],[@B23]\]. Despite negative microbiological tests, persister cells can reconstitute the biofilm, thus inducing the reoccurrence of symptoms in patients with chronic bacterial prostatitis.

3. Strengths and limitations of the present study
-------------------------------------------------

Although the present study findings were limited by the relatively small number of enrolled patients, this study should be regarded as an important pilot investigation for defining microbiological and ultrastructural characterization of prostate biopsy specimens. Our findings could thus be of value in defining future larger investigations. The combination of ultrastructural and cultural techniques applied to tissue samples obtained from the same subject indeed has the advantage of isolating and identifying the microorganisms associated with the prostatic tissue. Furthermore, this method allowed us to obtain direct information about their presence at the calcification surface in the aggregated form on the microbial biofilm. Moreover, possible contamination during tissue sampling could be excluded if biofilm architecture observed by SEM is typical of a mature biofilm embedded in the extracellular matrix. On the contrary, SEM has low sensitivity in detecting microbial biofilms within prostatic tissue. While high-resolution imaging is granted by using SEM, the identification of biofilms within the complex microscopic structure of the tissue biopsy limits the sensitivity of the overall technique. In addition, tissue sampling and processing can introduce morphological artifacts that complicate the identification of microorganisms, especially when noncoccoid species are present. This could explain why we were not able to identify microbial biofilms using SEM in the tissue of the patient with the biopsy culture positive for *C. freundii*. Further multicenter studies should be planned to better elucidate the intriguing role of bacterial biofilms in the genesis of prostate calcifications with the aim of defining new and more effective therapeutic strategies.

4. Clinical implications
------------------------

From a clinical point of view, this study has several implications. First, the clinical role of prostate calcifications should be reconsidered. In light of the findings reported here, prostate calcifications are not only a sonographic sign of previous prostatitis but should be considered a locus for difficult-to-treat bacteria (organized in a biofilm and having the potential to persist after common antibiotic treatments) within the prostate tissue. It is well known that not all patients with sonographic demonstration of prostate calcifications report clinical symptoms, but several authors have demonstrated that the presence and grade of prostate calcifications is associated with worsening of symptoms \[[@B4],[@B5],[@B7]\]. Moreover, some authors have reported that prostate calcifications are associated with prostate inflammation and symptoms \[[@B15],[@B24],[@B25]\]. Even if the natural history of prostate calcification is still not completely understood, we have added new data suggesting that bacterial biofilms might play a key role in the genesis of prostate calcifications and in the persistence of symptoms in a non-negligible fraction of antibiotic-treated patients. The presence of a bacterial biofilm represents a chronic inflammatory stimulus that could lead to the development of symptoms related to the grade of inflammation and the immune response of the patients. In the case of high-grade inflammation, the patient could report urinary or pelvic pain. The fluctuating symptomatology reported by the majority of patients might be explained by variation in the inflammatory response to the development and maturation of the bacterial biofilm. This hypothesis is supported by clinical observations that symptoms often decrease after antibiotic treatment but relapse after a variable period of time. The antibiotic treatment is probably effective in mitigating the grade of the infection but is not fully effective in eradicating the bacterial biofilm. Future studies should be designed to explore whether effective eradication of the bacterial biofilm could be associated with a good medium- and long-term clinical outcome of treatment.

CONCLUSIONS
===========

Although supported by a limited number of patients, this study presented evidence of the validity of the analytical methods of integrating cultural and ultrastructural techniques for characterizing tissue obtained from prostatic resection and suggests a possible role of bacterial biofilm in the genesis of prostate calcifications and in the development of symptoms in chronic prostatitis.
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![(A) Prostate core biopsy specimen showing several calcifications (brighter areas) within the tissue (darker areas). (B) Calcifications varied in size from a few to several hundred micrometers. (C) At high magnification, the calcification surface showed a crystalline structure with protein residuals and a possible extracellular polymeric matrix from the microbial biofilm. Scanning electron microscopy images were realized by collecting the signal from back-scattered electrons, giving compositional contrast between tissue and calcifications. (A) ×39, (B) ×500, (C) ×10,000.](icu-59-187-g001){#F1}

![(A) Prostate core biopsy specimen with calcifications and corpora amylacea (brighter areas) within the tissue (darker areas). (B) High-magnification details of some round-shaped structures, morphologically compatible with corpora amylacea. (C) Intratissual aggregate of microorganisms with coccoid morphology with extracellular polymeric matrix (microbial biofilm). Scanning electron microscopy images were realized by collecting the signal from back-scattered electrons (A) or secondary electrons to have the highest morphological detail. (A) ×100, (B) ×2,000, (C) ×8,000.](icu-59-187-g002){#F2}

###### Clinical and pathological characteristics of the enrolled patients

![](icu-59-187-i001)

  Characteristic         Patient no.                                                                                                                                      
  ---------------------- -------------------- ---------- ------------------- -------------- ---------- ---------- ------------------------- -------------- -------------- ----------
  Age (y)                65                   59         71                  63             62         57         61                        65             68             72
  cTNM                   T2 N0 M0             T3 N0 M0   T3 N0 M0            T2 N1 M0       T2 N0 M0   T3 N0 M0   T3 N0 M0                  T2 N1 M0       T3 N0 M0       T3 N0 M0
  Meares-Stamey          *Escherichia coli*   \-         \-                  \-             \-         \-         \-                        \-             \-             \-
  Concomitant diseases   Hypertension         No         Renal dysfunction   Hypertension   No         No         Cardiovascular diseases   Hypertension   Hypertension   Diabetes
  History of UTI         Yes                  No         No                  No             Yes        Yes        No                        No             No             No
  NIH-CPSI               17                   9          8                   7              8          5          5                         9              8              8
  IPSS                   15                   11         14                  19             17         11         10                        11             14             14

UTI, urinary tract infection; NIH-CPSI, National Institutes of Health Chronic Prostatitis Symptom Index; IPSS, International Prostate Symptom Score.
